COMPARISON OF THE EFFICACY AND TOLERABILITY OF TOCILIZUMAB, SARILUMAB, AND SIRUKUMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

被引：1

作者：

Lee, Y. H. ^{[1
]}

Seo, Y. H. ^{[1
]}

机构：

[1] Korea Univ, Med Ctr, Rheumatol, Seoul, South Korea

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷

关键词：

D O I：

10.1136/annrheumdis-2018-eular.1644

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SAT0167

引用

页码：944 / 944

页数：1

共 50 条

[1] Comparison of the efficacy and tolerability of tocilizumab, sarilumab, and sirukumab in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials
Sang-Cheol Bae
Young Ho Lee
[J]. Clinical Rheumatology, 2018, 37 : 1471 - 1479
[2] Comparison of the efficacy and tolerability of tocilizumab, sarilumab, and sirukumab in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials
Bae, Sang-Cheol
Lee, Young Ho
[J]. CLINICAL RHEUMATOLOGY, 2018, 37 (06) : 1471 - 1479
[3] Comparison of the efficacy and safety of tocilizumab, sarilumab, and sirukumab in comparison with adalimumab as monotherapy in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials
Sung, Yoon-Kyoung
Lee, Young Ho
[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (09) : 618 - 626
[4] Comparison of the efficacy and safety of tocilizumab, sarilumab, and olokizumab in patients with active rheumatoid arthritis: a network meta-analysis of randomized controlled trials
Ho Lee, Young
Gyu Song, Gwan
[J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2024, 83 (SUPPL 1): : 97 - 106
[5] Comparative efficacy and tolerability of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis A Bayesian network meta-analysis of randomized controlled trials
Bae, S. -C.
Lee, Y. H.
[J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2018, 77 (05): : 421 - 428
[6] Comparison of the efficacy and safety of tofacitinib and peficitinib in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials
Lee, Young Ho
Song, Gwan Gyu
[J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (07) : 868 - 875
[7] Comparison of the efficacy and safety of tofacitinib and filgotinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials
Lee, Y. H.
Song, G. G.
[J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (06): : 590 - 603
[8] Comparison of the efficacy and safety of tofacitinib and upadacitinib in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials
Song, Gwan Gyu
Choi, Sung Jae
Lee, Young Ho
[J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (08) : 1563 - 1571
[9] COMPARISON OF THE EFFICACY AND SAFETY OF TOFACITINIB AND UPADACITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Lee, Young Ho
Song, Gwan Gyu
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 751 - 751
[10] Comparison of the efficacy and safety of tofacitinib and mavrilimumab in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials
Sung, Yoon-Kyoung
Lee, Young Ho
[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (08) : 557 - 565

← 1 2 3 4 5 →